Y
Yehuda Shoenfeld
Researcher at Sheba Medical Center
Publications - 1714
Citations - 88070
Yehuda Shoenfeld is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Autoantibody & Antiphospholipid syndrome. The author has an hindex of 125, co-authored 1629 publications receiving 77195 citations. Previous affiliations of Yehuda Shoenfeld include Soroka Medical Center & Saint Petersburg State University.
Papers
More filters
Journal ArticleDOI
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Spiros Miyakis,Michael D. Lockshin,Tatsuya Atsumi,D W Branch,Robin L. Brey,Ricard Cervera,R. H. W. M. Derksen,P. G. De Groot,Takao Koike,Pier Luigi Meroni,Guido Reber,Yehuda Shoenfeld,Angela Tincani,Panayiotis G. Vlachoyiannopoulos,Steven A. Krilis +14 more
TL;DR: This document appraise the existing evidence on clinical and laboratory features of APS addressed during the forum and proposes amendments to the Sapporo criteria, including definitions on features ofAPS that were not included in the updated criteria.
Journal ArticleDOI
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Ricard Cervera,J.C. Piette,Josep Font,Munther A. Khamashta,Yehuda Shoenfeld,María Teresa Camps,Søren Jacobsen,Gabriella Lakos,Angela Tincani,Irene Kontopoulou-Griva,Mauro Galeazzi,Pier Luigi Meroni,Ronald H. W. M. Derksen,Philip G. de Groot,Erika Gromnica-Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,Frédéric Houssiau,Jean-Christophe Gris,Isabelle Quéré,Eric Hachulla,Carlos Vasconcelos,B. Roch,Antonio Fernández-Nebro,Marie Claire Boffa,Graham R. V. Hughes,Miguel Ingelmo +27 more
TL;DR: An association with SLE, the patient's sex, and the patient’s age at disease onset can modify the disease expression and define specific subsets of APS.
Journal ArticleDOI
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.
Claudio Vitali,Stefano Bombardieri,Haralampos M. Moutsopoulos,Genesio Balestrieri,Walter Bencivelli,Robert M. Bernstein,Kirsten B. Bjerrum,Susanna Braga,J Coll,Salvatore De Vita,Alexandros A. Drosos,Michael Ehrenfeld,Pierre Y. Hatron,Elaine M Hay,David A. Isenberg,Anne Janin,Joachim R. Kalden,Louis Kater,Yrjö T. Konttinen,Peter J. Maddison,Ravinder N. Maini,Rolf Manthorpe,Olivier Meyer,Pierantonio Ostuni,Y.L. Pennec,Jan Ulrik Prause,Andrea Richards,Bernard Sauvezie,Morten Schiødt,Maria Sciuto,Crispian Scully,Yehuda Shoenfeld,Fotini N. Skopouli,Josef S. Smolen,M L Snaith,Moshe Tishler,Silvano Todesco,Guido Valesini,Patrick J Venables,Marie J. Wattiaux,Pierre Youinou +40 more
TL;DR: Using the findings of this prospective multicenter European study, general agreement can be reached on the diagnostic procedures to be used for patients with SS.
Journal ArticleDOI
Effects of tobacco smoke on immunity, inflammation and autoimmunity
TL;DR: The current review underlines the importance of smoking prevention and eradication not only in respiratory disorders but also in autoimmune conditions as well.
Journal ArticleDOI
'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.
TL;DR: The current data regarding the role of adjuvants in the pathogenesis of immune mediated diseases as well as the amassed data regarding each of these four conditions are reviewed to suggest to include these comparable conditions under a common syndrome entitled ASIA, "Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants".